ロード中...
Dual HER2 Blockade in Neoadjuvant Treatment of HER2+ Breast Cancer: A Meta-Analysis and Review
BACKGROUND: To investigate the pathologic complete response (pCR) rates of dual human epidermal growth factor receptor 2 (HER2) blockade in a neoadjuvant setting for HER2+ breast cancer. METHODS: We searched randomized clinical trials (RCTs) using dual HER2 blockade in a neoadjuvant setting for HER2...
保存先:
| 出版年: | Technol Cancer Res Treat |
|---|---|
| 主要な著者: | , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
SAGE Publications
2020
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7534077/ https://ncbi.nlm.nih.gov/pubmed/32990165 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1533033820960721 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|